Global Epilepsy Market Report 2021

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epilepsy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Partial/focal Seizure
1.2.3 Generalized Seizure
1.2.4 Myoclonus Misses
1.2.5 Negative Myoclonus
1.2.6 Eyelid Myoclonus
1.2.7 Laughter
1.2.8 Others
1.3 Market by Application
1.3.1 Global Epilepsy Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Home Care Settings
1.3.5 Ambulatory Surgical Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epilepsy Market Perspective (2015-2026)
2.2 Global Epilepsy Growth Trends by Regions
2.2.1 Epilepsy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epilepsy Historic Market Share by Regions (2015-2020)
2.2.3 Epilepsy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Players by Market Size
3.1.1 Global Top Epilepsy Players by Revenue (2015-2020)
3.1.2 Global Epilepsy Revenue Market Share by Players (2015-2020)
3.2 Global Epilepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epilepsy Revenue
3.4 Global Epilepsy Market Concentration Ratio
3.4.1 Global Epilepsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Revenue in 2019
3.5 Key Players Epilepsy Area Served
3.6 Key Players Epilepsy Product Solution and Service
3.7 Date of Enter into Epilepsy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Breakdown Data by Type (2015-2026)
4.1 Global Epilepsy Historic Market Size by Type (2015-2020)
4.2 Global Epilepsy Forecasted Market Size by Type (2021-2026)

5 Epilepsy Breakdown Data by Application (2015-2026)
5.1 Global Epilepsy Historic Market Size by Application (2015-2020)
5.2 Global Epilepsy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Epilepsy Market Size (2015-2026)
6.2 North America Epilepsy Market Size by Type (2015-2020)
6.3 North America Epilepsy Market Size by Application (2015-2020)
6.4 North America Epilepsy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Epilepsy Market Size (2015-2026)
7.2 Europe Epilepsy Market Size by Type (2015-2020)
7.3 Europe Epilepsy Market Size by Application (2015-2020)
7.4 Europe Epilepsy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Epilepsy Market Size (2015-2026)
8.2 China Epilepsy Market Size by Type (2015-2020)
8.3 China Epilepsy Market Size by Application (2015-2020)
8.4 China Epilepsy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Epilepsy Market Size (2015-2026)
9.2 Japan Epilepsy Market Size by Type (2015-2020)
9.3 Japan Epilepsy Market Size by Application (2015-2020)
9.4 Japan Epilepsy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Epilepsy Market Size (2015-2026)
10.2 Southeast Asia Epilepsy Market Size by Type (2015-2020)
10.3 Southeast Asia Epilepsy Market Size by Application (2015-2020)
10.4 Southeast Asia Epilepsy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 LivaNova
11.1.1 LivaNova Company Details
11.1.2 LivaNova Business Overview
11.1.3 LivaNova Epilepsy Introduction
11.1.4 LivaNova Revenue in Epilepsy Business (2015-2020))
11.1.5 LivaNova Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Details
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Epilepsy Introduction
11.2.4 Johnson & Johnson Services Revenue in Epilepsy Business (2015-2020)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Epilepsy Introduction
11.3.4 Eisai Revenue in Epilepsy Business (2015-2020)
11.3.5 Eisai Recent Development
11.4 GlaxoSmithKline PLC
11.4.1 GlaxoSmithKline PLC Company Details
11.4.2 GlaxoSmithKline PLC Business Overview
11.4.3 GlaxoSmithKline PLC Epilepsy Introduction
11.4.4 GlaxoSmithKline PLC Revenue in Epilepsy Business (2015-2020)
11.4.5 GlaxoSmithKline PLC Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Epilepsy Introduction
11.5.4 Pfizer Revenue in Epilepsy Business (2015-2020)
11.5.5 Pfizer Recent Development
11.6 UCB SA
11.6.1 UCB SA Company Details
11.6.2 UCB SA Business Overview
11.6.3 UCB SA Epilepsy Introduction
11.6.4 UCB SA Revenue in Epilepsy Business (2015-2020)
11.6.5 UCB SA Recent Development
11.7 Medtronic PLC (Ireland)
11.7.1 Medtronic PLC (Ireland) Company Details
11.7.2 Medtronic PLC (Ireland) Business Overview
11.7.3 Medtronic PLC (Ireland) Epilepsy Introduction
11.7.4 Medtronic PLC (Ireland) Revenue in Epilepsy Business (2015-2020)
11.7.5 Medtronic PLC (Ireland) Recent Development
11.8 NeuroPace
11.8.1 NeuroPace Company Details
11.8.2 NeuroPace Business Overview
11.8.3 NeuroPace Epilepsy Introduction
11.8.4 NeuroPace Revenue in Epilepsy Business (2015-2020)
11.8.5 NeuroPace Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Epilepsy Introduction
11.9.4 Novartis AG Revenue in Epilepsy Business (2015-2020)
11.9.5 Novartis AG Recent Development
11.10 GW Pharmaceuticals
11.10.1 GW Pharmaceuticals Company Details
11.10.2 GW Pharmaceuticals Business Overview
11.10.3 GW Pharmaceuticals Epilepsy Introduction
11.10.4 GW Pharmaceuticals Revenue in Epilepsy Business (2015-2020)
11.10.5 GW Pharmaceuticals Recent Development
11.11 Abbott Laboratories
10.11.1 Abbott Laboratories Company Details
10.11.2 Abbott Laboratories Business Overview
10.11.3 Abbott Laboratories Epilepsy Introduction
10.11.4 Abbott Laboratories Revenue in Epilepsy Business (2015-2020)
10.11.5 Abbott Laboratories Recent Development
11.12 Sanofi
10.12.1 Sanofi Company Details
10.12.2 Sanofi Business Overview
10.12.3 Sanofi Epilepsy Introduction
10.12.4 Sanofi Revenue in Epilepsy Business (2015-2020)
10.12.5 Sanofi Recent Development
11.13 Sunovion Pharmaceuticals
10.13.1 Sunovion Pharmaceuticals Company Details
10.13.2 Sunovion Pharmaceuticals Business Overview
10.13.3 Sunovion Pharmaceuticals Epilepsy Introduction
10.13.4 Sunovion Pharmaceuticals Revenue in Epilepsy Business (2015-2020)
10.13.5 Sunovion Pharmaceuticals Recent Development
11.14 Bausch Health
10.14.1 Bausch Health Company Details
10.14.2 Bausch Health Business Overview
10.14.3 Bausch Health Epilepsy Introduction
10.14.4 Bausch Health Revenue in Epilepsy Business (2015-2020)
10.14.5 Bausch Health Recent Development
11.15 Takeda
10.15.1 Takeda Company Details
10.15.2 Takeda Business Overview
10.15.3 Takeda Epilepsy Introduction
10.15.4 Takeda Revenue in Epilepsy Business (2015-2020)
10.15.5 Takeda Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details